Potential Oral Stargardt Treatment Advances to Phase 3 Clinical Trial
Jun 18, 20264m
Promising oral treatment moves closer for Stargardt patients.
Hosted by Unknown Host · 🇺🇸 us · EN · 258 episodes
Established thought leaders with verified media credentials.
The Foundation Fighting Blindness is the driving force in the global development of treatments and cures for blinding diseases. To learn more, go to FightingBlindness.org.
Unknown Host hosts Foundation Fighting Blindness, a science show with 258 episodes published.
Promising oral treatment moves closer for Stargardt patients.
2020 Llura Liggett Gund Award recipient honored for pioneering gene therapy that transformed vision research
Data monitoring committee recommends proceeding with registration-enabling study for ATSN-201
MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP) by Foundation Fighting Blindness
Strategic funding extends cash runway through 2029 and advances multiple inherited retinal disease programs
VG801 shows sustained vision improvements through 12 months with favorable safety profile
Potential cell therapy, DSP-3077, gains special regulatory status to support development for inherited retinal disease.
First-of-its-kind small molecule therapy targets protein misfolding at the root of RHO-adRP
First patient shows vision improvements with a good safety profile.
To celebrate episode 100 of Eye on the Cure, host Ben Shaberman features highlights from conversations with some of his previous guests including: Dr. Dean Bok from UCLA, Dr. Michel Michaelides from Moorfields Eye Hospit
Novel neuroprotective approach could benefit RP patients regardless of genetic mutation
Listen to the latest episode of the Blind & Beyond radio show featuring Foundation Fighting Blindness CEO Jason Menzo. Jason discusses the Foundation's mission and the remarkable progress achieved over the past 55 years
Dr. Prem Subramanian, of the University of Colorado Sue Anschutz-Rodgers Eye Center and School of Medicine, talks with host Ben Shaberman about thyroid eye disease (TED), a condition that is often misdiagnosed and can ca
Marking an important milestone for this rare form of retinitis pigmentosa (RP)
Milestone brings hope to patients with rare inherited retinal disease
First patient treated in Part B of ASTRA trial evaluating SB-007.
Josh Steinberg and his father, Jon, talk with host Ben Shaberman about their close-knit family's journey with Josh's vision loss and eventual diagnosis of retinitis pigmentosa, as well as their volunteer leadership roles
Lindsey Rambo, a special education teaching assistant, mom, and wife, talks to host Ben Shaberman about her journey with Leber congenital amaurosis 5 (LCA5), participation in Opus Genetics' LCA5 gene therapy clinical tri
The company has also fully enrolled the Phase 2/3 VISTA clinical trial for its XLRP gene therapy.
Dr. Deniz Dalkara, a research director at INSERM in France, talks to hose Ben Shaberman about her emerging gene-agnostic, gene therapy designed to restore cone-mediated vision in people with advanced retinitis pigmentosa
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Foundation Fighting Blindness has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their science audience.
Foundation Fighting Blindness is hosted by Unknown Host. The show is categorised under science and has published 258 episodes.
Foundation Fighting Blindness has published 258 episodes.
Foundation Fighting Blindness regularly covers science. It sits in the science category.
Foundation Fighting Blindness is accessible for guests with genuine science expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
Foundation Fighting Blindness hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of Foundation Fighting Blindness average 13 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates Foundation Fighting Blindness's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 12 days ago.